möglich sobald bei der ZB eingereicht worden ist.
Proenkephalin predicts kidney function and major adverse kidney events in CKD.
Nephrol. Dial. Transplant., DOI: 10.1093/ndt/gfaf214 (2025)
BACKGROUND AND HYPOTHESIS: The endogenous opioid proenkephalin (PENK) has been identified as an independent risk marker for acute cardiovascular diseases and acute kidney injury (AKI). However, its regulation, its association with other cardiometabolic markers, and its prognostic role in patients with chronic kidney disease (CKD) have not been thoroughly investigated. METHODS: PENK serum levels were cross-sectionally related to renal and cardiometabolic markers across three large cohorts (total N = 4 722), including the Leipzig-CKD cohort (N = 581), as well as the population-based LIFE-Adult (N = 3 093) and Sorbs (N = 1 048) cohort. Furthermore, a longitudinal analysis was performed in the Leipzig-CKD cohort to assess the association between circulating PENK levels at baseline and a composite 4-point major adverse renal events (4P-MARE)-endpoint comprising incident or worsening kidney disease, development of kidney failure (KF) requiring kidney replacement therapy or kidney transplantation, and renal deaths. RESULTS: In the entire cross-sectional cohort (N = 4 722), PENK levels were strongly and inversely correlated with markers of renal function, i.e. estimated glomerular filtration rate (eGFR), creatinine, and urinary albumin creatinine ratio (uACR). In multivariable analysis, eGFR was the strongest, independent, and inverse predictor of circulating PENK levels after adjustment for age, sex, as well as markers of obesity, glucose intolerance, dyslipidemia, and inflammation.Multivariable Cox regression analysis revealed that baseline circulating PENK levels were strongly associated with an increased risk of the 4P-MARE over a median follow-up of 8.7 years. Each doubling of PENK levels was associated with a more than two-fold increase in the risk of developing 4P-MARE, even after adjusting for various clinical and metabolic variables. PENK provided added value for predicting adverse renal outcomes. CONCLUSIONS: PENK levels are strongly, independently, and inversely associated with renal function in cross-sectional analysis. Furthermore, baseline circulating PENK levels are predictive of a 4P-MARE in patients and added independent, prognostic value for identification of patients at risk for adverse renal outcomes.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Cardiometabolic Disease ; Major Adverse Renal Events ; Proenkephalin ; Renal Function
Sprache
englisch
Veröffentlichungsjahr
2025
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
0931-0509
e-ISSN
1460-2385
Zeitschrift
Nephrology Dialysis Transplantation
Verlag
Oxford University Press
Begutachtungsstatus
Peer reviewed
Institut(e)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-506501-001
PubMed ID
41105147
Erfassungsdatum
2025-10-23